{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:30:27Z","timestamp":1769844627976,"version":"3.49.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/ftd.0b013e31829a10fa","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T07:10:41Z","timestamp":1380611441000},"page":"844-848","source":"Crossref","is-referenced-by-count":31,"title":["A UPLC-MS\/MS Method for Therapeutic Drug Monitoring of Etonogestrel"],"prefix":"10.1097","volume":"35","author":[{"given":"Tiffany","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joonho","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten M.","family":"Abildskov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn L.","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Cremers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210129","first-page":"585","article-title":"Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring.","volume":"100","author":"Dieben","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R2-15-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring.","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"R3-15-20210129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":". Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive.","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"R4-15-20210129","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.contraception.2010.04.016","article-title":"Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review.","volume":"82","author":"Edelman","year":"2010","journal-title":"Contraception"},{"key":"R5-15-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9378(16)33897-2","article-title":". Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate.","volume":"107","author":"Mishell","year":"1970","journal-title":"Am J Obstet Gynecol"},{"key":"R6-15-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.contraception.2010.07.008","article-title":"Vaginal ring contraception.","volume":"83","author":"Kerns","year":"2011","journal-title":"Contraception"},{"key":"R7-15-20210129","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","article-title":". Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial.","volume":"71","author":"Oddsson","year":"2005","journal-title":"Contraception"},{"key":"R8-15-20210129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humrep\/16.3.469","article-title":". Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.","volume":"16","author":"Roumen","year":"2001","journal-title":"Hum Reprod"},{"key":"R9-15-20210129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.contraception.2010.08.015","article-title":". New strategies for providing hormonal contraception in developing countries.","volume":"83","author":"Townsend","year":"2011","journal-title":"Contraception"},{"key":"R10-15-20210129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2307\/2991640","article-title":". Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth.","volume":"31","author":"Fu","year":"1999","journal-title":"Fam Plann Perspect"},{"key":"R11-15-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0091270002239706","article-title":"The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetateethinyl estradiol tablets intended for continuous hormone replacement therapy.","volume":"43","author":"Boyd","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"pt 1","key":"R12-15-20210129","first-page":"820","article-title":"Body weight and risk of oral contraceptive failure.","volume":"99","author":"Holt","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R13-15-20210129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.AOG.0000149155.11912.52","article-title":". Body mass index, weight, and oral contraceptive failure risk.","volume":"105","author":"Holt","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"suppl 2","key":"R14-15-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/14730782.2000.12288981","article-title":"The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant.","volume":"5","author":"Bennink","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R15-15-20210129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00216-011-5612-0","article-title":". Simultaneous online SPE-LC-MSMS quantification of six widely used synthetic progestins in human plasma.","volume":"403","author":"Moser","year":"2012","journal-title":"Anal Bioanal Chem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31829a10fa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T09:35:06Z","timestamp":1716024906000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201312000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31829a10fa","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}